Need Tally
for Clients?

Contact Us! Here

  Tally Auditor

License (Renewal)
  Tally Gold

License Renewal

  Tally Silver

License Renewal
  Tally Silver

New Licence
  Tally Gold

New Licence
 
Open DEMAT Account with in 24 Hrs and start investing now!
« Top Headlines »
Open DEMAT Account in 24 hrs
 How To File ITR Online - Step by Step Guide to Efile Income Tax Return, FY 2023-24 (AY 2024-25)
 Old or new tax regime for TDS on salary? This post-election 2024 event will impact your tax planning
 What Are 5 Heads Of Income Tax?
 Income Tax Dept releases interim action plan for FY25 on tax collection, refund approvals
  Income Tax Return: 5 lesser-known tax-saving tips from Section 80
 Income Tax Return: 5 lesser-known tax-saving tips from Section 80
 Why you need not rush to file your ITR immediately
 Income tax returns: ITR-1, ITR-2, ITR-4 forms for FY 2023-24 available for e-filing
 Section 80DDB tax benefits for specified illnesses: 5 things to know
 Income tax slabs FY 2024-25: Five tips to help taxpayers decide between old and new income tax regimes
 ITR-1, ITR-2, ITR-4 forms for FY 2023-24 (AY 2024-25) available now on e-filing income tax portal

`MRP on drugs manufactured after Oct 2 will be inclusive of taxes'
November, 10th 2006

The Tamil Nadu Chemists & Druggists Association (TCDA) has announced that the MRP (maximum retail price) on drugs manufactured after October 2 will be inclusive of taxes in line with the Union Government's order dated June 26, according to Mr M. Arulkumar, General Secretary, TCDA.

He told that medicines manufactured earlier would continue to quote MRP without including local taxes. This could create confusion among customers, as these stocks are likely to be on the shelves for three to six months, he said.

Recently, 11 top manufacturers cut prices on 886 branded drugs but this will not create a big impact on the buyers. These account for just 1 to 2 per cent of the all-India pharmaceutical sales, which is estimated around Rs 50,000 crore per month. The pharmaceutical sales in Tamil Nadu are estimated around Rs 600 crore per month and Chennai accounts for Rs 200 crore of this.

Mr Arulkumar said that the Government recently reduced the prices of generic drugs (not the branded products), which accounts for just five per cent of pharmaceutical sales. The problem, here, for the consumer is that most doctors prescribe brand names and not the generic name, he said. He also appealed to the Government to bring in a uniform reduction in prices of life-saving drugs.

Home | About Us | Terms and Conditions | Contact Us
Copyright 2024 CAinINDIA All Right Reserved.
Designed and Developed by Ritz Consulting